Increased Vascular Comorbidities Linked to Decreased Neuroperformance in MS
Vascular comorbidity burden among patients with multiple sclerosis may be associated with neurologic dysfunction and neurodegeneration.
Neurodegenerative Diseases
Communication Challenges in Caring for Patients Facing Palliative Care
In this qualitative study, researchers explored the current approaches, communication experiences, and challenges facing neurology interdisciplinary health professionals in palliative care.
Anti-VEGF Injections Associated With Cognitive Decline
Researchers evaluated the brain health assessment scores of patients who received treatments for AMD.
Sleep Quality and Cognitive Function in Patients With Mild Traumatic Brain Injury
Researchers compared sleep quality and biomarkers of neurodegeneration and cognitive scores between so-called poor sleepers and good sleepers with mild traumatic brain injury.
Influenza Vaccination Does Not Increase Risk for Guillain-Barré Syndrome
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
Investigational Drug May Prolong Survival in Patients With ALS
Long-term survival analysis shows that patients with earlier initiation of sodium PB-TURSO treatment for ALS have longer median overall survival.
Literature Review Explores Potential Neuroprotective Effects of Resveratrol
The eligibility criteria of the studies include: a maximum of 10 years having passed from the study publication, geographical diversity of the studies performed, and results pertaining both to animal models of AD, and to humans.
Clinical Benefits of Multidisciplinary Rehabilitation in Premanifest HD
Participants in the multidisciplinary intervention group had significant improvements in verbal learning and memory, attention, cognitive flexibility, and processing speed.
Phase 1 Trial Suggests PD01A Is Safe in Parkinson Disease Treatment
A Phase 1 trial suggested that PD01A was safe and well tolerated over an extended period in patients with Parkinson disease.
CNS-Active Meds Often Prescribed for Older Adults With Dementia
The researchers found that 73.5 percent of the 737,839 community-dwelling beneficiaries with dementia were prescribed any CNS-active medication.
-
Loading...
-
Loading...
Next post in Neurodegenerative Diseases
